The Filing Desk

Baird Medical Investment vs Jin Medical International

Baird Medical Investment BDMD · Jin Medical International ZJYL · Health Care Equipment

Baird Medical Investment reported revenue of $22 million in fiscal 2025, about the same as Jin Medical International's $21 million in fiscal 2025. Baird Medical Investment's revenue fell 39.1% in its latest year, and Jin Medical International's fell 12.0%. Baird Medical Investment had an operating margin of -113.7%, against 2.9% at Jin Medical International. Free cash flow was −$1 million at Baird Medical Investment and −$4 million at Jin Medical International. Their fiscal years end in different months (December 31 and September 30), so the periods don't line up exactly.

Side by side

Baird Medical InvestmentJin Medical International
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Sep 30, 2025
Revenue$22M$21M
Revenue growth−39.1%−12.0%
Revenue growth a year, last 5 years——
Gross margin83.8%29.2%
Operating margin−113.7%2.9%
Net margin−121.0%5.8%
Free cash flow−$1M−$4M
Free cash flow margin−6.2%−18.0%
Return on capital−50.0%—
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count27.3%0.1%
Last close$0.10$3.34
P/E at the last close——
Insider trades, last 12 months——
Piotroski F-score1 of 9—
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Baird Medical InvestmentJin Medical International
Operating margin
Percent of revenue
Baird Medical InvestmentJin Medical International
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Baird Medical InvestmentJin Medical International

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Baird Medical Investment and Jin Medical International pages.